Björn van Anrooij

International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study

Wolfgang R. Sperr, Michael Kundi, Iván Álvarez‐Twöse et al. · The Lancet Haematology · 2019 · 138 citations · Full text

Life Sciences, Health Sciences, Diagnostic Pathology +6

Higher mast cell load decreases the risk of Hymenoptera venom–induced anaphylaxis in patients with mastocytosis

Björn van Anrooij, E. van der Veer, Jan G.R. de Monchy et al. · Journal of Allergy and Clinical Immunology · 2013 · 90 citations

Life Sciences, Immunology, Internal Medicine +14

Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification

Jakub Trizuljak, Wolfgang R. Sperr, Lucie Nekvindová et al. · Allergy · 2020 · 77 citations · Full text

Medicine, Oncology, Pathology +9

Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients

Byrthe J.P.R. Vos, Björn van Anrooij, Jasper J. van Doormaal et al. · The Journal of Allergy and Clinical Immunology In Practice · 2017 · 64 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis

Björn van Anrooij, Hanneke C. Kluin‐Nelemans, M. Safy et al. · Allergy · 2016 · 59 citations

Life Sciences, Immunology, Internal Medicine +17